mhurhangee/patent-ind-claim-en huggingface dataset:
An autostereoscopic display having a pass through transparent function, comprising: a display panel having an array of light emitting display pixels occupying pixel areas, and a light transmissive area between the pixel areas; and a polarizer at only the light transmissive area , wherein the light emitting display pixels provide light of a first polarization which is orthogonal to a second polarization passed by the polarizer ; and an image forming arrangement for directing images from different sets of pixels in different lateral viewing directions thereby enabling autostereoscopic viewing, wherein the image forming arrangement is provided over one or both sides of the display, wherein the image forming arrangement is used to form autostereoscopic images using light of the first polarization, whereas light of the second polarization is used for the pass through transparent function. a display panel having an array of light emitting display pixels occupying pixel areas, and a light transmissive area between the pixel areas; and a polarizer at only the light transmissive area , wherein the light emitting display pixels provide light of a first polarization which is orthogonal to a second polarization passed by the polarizer ; and an image forming arrangement for directing images from different sets of pixels in different lateral viewing directions thereby enabling autostereoscopic viewing, wherein the image forming arrangement is provided over one or both sides of the display, wherein the image forming arrangement is used to form autostereoscopic images using light of the first polarization, whereas light of the second polarization is used for the pass through transparent function.
A compound of Formula I wherein R1 is selected from the group consisting of C 1 -C 6 alkyl, CF 3 , CH 2 CF 3 , CF 2 CHF 2 , C 3 -C 8 cycloalkyl, wherein said C 3 -C 8 cycloalkyl may be substituted with 1 or 2 substituents selected from the group consisting of C 1 -C 3 alkyl, F, CHF 2 and CF 3; and R2 is H, C 1 -C 6 alkyl or CF 3 ; or R1 and R2 combine to form C 3 -C 5 cycloalkyl optionally substituted with 1 or 2 F, CHF 2 or CF 3 ; and R3 is C 1 -C 3 alkyl or CH 2 O-C 1-3 alkyl, said C 1 -C 3 alkyl or CH 2 O-C 1- C 3 alkyl is substituted with C≡N, 3 F or C 3 -C 5 cycloalkyl; R4 is selected from the group consisting of OCF 3 , or OCHF 2 or a pharmaceutically acceptable salt of any of these compounds. R1 is selected from the group consisting of C 1 -C 6 alkyl, CF 3 , CH 2 CF 3 , CF 2 CHF 2 , C 3 -C 8 cycloalkyl, wherein said C 3 -C 8 cycloalkyl may be substituted with 1 or 2 substituents selected from the group consisting of C 1 -C 3 alkyl, F, CHF 2 and CF 3; and R2 is H, C 1 -C 6 alkyl or CF 3 ; or R1 and R2 combine to form C 3 -C 5 cycloalkyl optionally substituted with 1 or 2 F, CHF 2 or CF 3 ; and R3 is C 1 -C 3 alkyl or CH 2 O-C 1-3 alkyl, said C 1 -C 3 alkyl or CH 2 O-C 1- C 3 alkyl is substituted with C≡N, 3 F or C 3 -C 5 cycloalkyl; R4 is selected from the group consisting of OCF 3 , or OCHF 2
A surgical needle assembly for attachment to an ophthalmic ultrasonic handpiece comprising: an elongated metal cannula having a distal end and a proximal end ; a hub insert molded onto the cannula generally towards the cannula proximal end for transmitting ultrasonic vibrations from a vibration source through the hub and the cannula and formed from a material having an ultimate strength at least twice a peak cyclical stress force or an endurance strength equal to or greater than a peak cyclical stress force at a joint between the elongated metal cannula and the hub when the surgical needle assembly is in use under normal ultrasonic cyclical vibrations with the ultrasonic handpiece ; wherein the hub material has a stiffness sufficient to limit a motion of the elongated metal cannula to less than 1.5 times an expected peak to peak stroke length when the surgical needle assembly is in use with the ultrasonic handpiece ; and wherein the hub includes structure for mating attachment to the ultrasonic handpiece . an elongated metal cannula having a distal end and a proximal end ; a hub insert molded onto the cannula generally towards the cannula proximal end for transmitting ultrasonic vibrations from a vibration source through the hub and the cannula and formed from a material having an ultimate strength at least twice a peak cyclical stress force or an endurance strength equal to or greater than a peak cyclical stress force at a joint between the elongated metal cannula and the hub when the surgical needle assembly is in use under normal ultrasonic cyclical vibrations with the ultrasonic handpiece ; wherein the hub material has a stiffness sufficient to limit a motion of the elongated metal cannula to less than 1.5 times an expected peak to peak stroke length when the surgical needle assembly is in use with the ultrasonic handpiece ; and wherein the hub includes structure for mating attachment to the ultrasonic handpiece .
Shell and tube heat exchanger for exchanging heat between a first and second fluid, whereby the heat exchanger comprises a housing in which one or more tubes extend between an inlet section for the first fluid and an outlet section for the first fluid, whereby baffles are affixed in the housing , whereby the baffles are provided with passages , whereby the one or more tubes extend through the said passages , whereby the baffles are connected to one another at a distance from one another by means of one or more fastening elements that are affixed in first recesses in the baffles , characterised in that one or more connections between a said baffle and a said fastening element are formed by means of one or more lips that are made at an edge of a first recess , whereby the one or more lips form part of the baffle and whereby the one or more lips are bent over, out of the plane defined by the baffle .
System comprising an antenna (ANT2), communication means configured for receiving and/or transmitting information via the said antenna according to a contactless communications protocol comprising an input and output interface , charging means configured for carrying out a contactless charging of a power supply module via the said antenna (ANT2), and control means configured for selectively rendering the communication means or the charging means operational, in which system the communication means are configured for receiving and/or transmitting information via the said antenna at a first frequency, the charging means are configured for carrying out a contactless charging of the power supply module via the said antenna at a second frequency and the control means comprise a first configurable control block designed to both select the communication means or the charging means by a frequency switching between the first and the second frequency and to isolate the communication means from the said antenna when the charging means are selected, the first control block comprising a configurable matching circuit coupled to the said antenna (ANT2) having a first configuration in which it is connected between the said antenna and the said input and output interface and forms with the said antenna a first resonant circuit having the said first frequency as resonance frequency or else it forms a matched circuit with an impedance compatible with the transmission/reception of information via the said antenna at the said first frequency, and a second configuration in which it is connected between the said antenna and a power supply cold point (GND), the said input and output interface being also connected to the said power supply cold point (GND), and it forms a second resonant circuit with the said antenna having the said second frequency as resonance frequency. a first configuration in which it is connected between the said antenna and the said input and output interface and forms with the said antenna a first resonant circuit having the said first frequency as resonance frequency or else it forms a matched circuit with an impedance compatible with the transmission/reception of information via the said antenna at the said first frequency, and a second configuration in which it is connected between the said antenna and a power supply cold point (GND), the said input and output interface being also connected to the said power supply cold point (GND), and it forms a second resonant circuit with the said antenna having the said second frequency as resonance frequency.
A dialysate-extracting apparatus (A, B) comprising: a dialysate-extracting device having an introduction port and a discharge port each of which is connected to a flow route for liquid and allows the liquid to flow therethrough, and a collecting port from which the liquid flowing in the flow route is collectable; characterized in that the dialysate-extracting apparatus (A, B) further comprises: an opening-and-closing device that is movable between a closing position where the opening-and-closing device covers the collecting port of the dialysate-extracting device and an opening position where the opening-and-closing device opens the collecting port , and an ultraviolet-applying device attached to the opening-and-closing device and that is capable of applying ultraviolet rays to the collecting port when the opening-and-closing device is at the closing position. a dialysate-extracting device having an introduction port and a discharge port each of which is connected to a flow route for liquid and allows the liquid to flow therethrough, and a collecting port from which the liquid flowing in the flow route is collectable; characterized in that the dialysate-extracting apparatus (A, B) further comprises: an opening-and-closing device that is movable between a closing position where the opening-and-closing device covers the collecting port of the dialysate-extracting device and an opening position where the opening-and-closing device opens the collecting port , and an ultraviolet-applying device attached to the opening-and-closing device and that is capable of applying ultraviolet rays to the collecting port when the opening-and-closing device is at the closing position. an opening-and-closing device that is movable between a closing position where the opening-and-closing device covers the collecting port of the dialysate-extracting device and an opening position where the opening-and-closing device opens the collecting port , and an ultraviolet-applying device attached to the opening-and-closing device and that is capable of applying ultraviolet rays to the collecting port when the opening-and-closing device is at the closing position.
A curable organopolysiloxane composition, containing the following components (A) to (G): (A) 100 parts by mass of an organopolysiloxane having at least two alkenyl groups per one molecule; (B) 0.05 to 10 parts by mass of a trialcoxysilyl containing siloxane having one silicon atom-bonded hydrogen atom and at least one trialcoxysilyl group per one molecule and represented by the following formula. (wherein R 1 is the same or different monovalent hydrocarbon group not having an aliphatic unsaturated bond, R 2 is an alkyl group, R 3 is an alkylene group, and p is an integer of 1 to 50.); (C) 0.1 to 30 parts by mass of a chain or cyclic organopolysiloxane having at least two silicon atom-bonded hydrogen atoms per one molecule; (D) 0.1 to 10 parts by mass of a chain organopolysiloxane having at least three silicon atom-bonded hydrogen atoms per one molecule, {wherein the total amount of the silicon atom-bonded hydrogen atoms of (B), (C), and (D) with respect to the number of the alkenyl groups in all the components is 0.3 to 10}; (E) a catalyst amount of a catalyst for a hydrosilylation reaction; (F) a catalyst amount of a catalyst for a condensation reaction; and (G) an adhesion promoter. (A) 100 parts by mass of an organopolysiloxane having at least two alkenyl groups per one molecule; (B) 0.05 to 10 parts by mass of a trialcoxysilyl containing siloxane having one silicon atom-bonded hydrogen atom and at least one trialcoxysilyl group per one molecule and represented by the following formula. (wherein R 1 is the same or different monovalent hydrocarbon group not having an aliphatic unsaturated bond, R 2 is an alkyl group, R 3 is an alkylene group, and p is an integer of 1 to 50.); (C) 0.1 to 30 parts by mass of a chain or cyclic organopolysiloxane having at least two silicon atom-bonded hydrogen atoms per one molecule; (D) 0.1 to 10 parts by mass of a chain organopolysiloxane having at least three silicon atom-bonded hydrogen atoms per one molecule, {wherein the total amount of the silicon atom-bonded hydrogen atoms of (B), (C), and (D) with respect to the number of the alkenyl groups in all the components is 0.3 to 10}; (E) a catalyst amount of a catalyst for a hydrosilylation reaction; (F) a catalyst amount of a catalyst for a condensation reaction; and (G) an adhesion promoter.
A braking module for a railway vehicle, comprising: a disk comprising a disk body and a plurality of fixing units , the disk body having an opening portion formed at a center of the disk, the fixing units protruding from an inner surface of the disk body toward the opening ; a hub comprising a central frame , an upper surface portion and a plurality of combining blocks , the central frame having a central hole , the upper surface portion being formed at an end of the central frame, the combining blocks being formed on the upper surface portion and being inserted between the fixing units; characterised by an elastic unit integrally formed, and disposed on the fixing units or beneath the upper surface portion; and a combining unit fixing the fixing units, the upper surface portion and the elastic unit with each other. a disk comprising a disk body and a plurality of fixing units , the disk body having an opening portion formed at a center of the disk, the fixing units protruding from an inner surface of the disk body toward the opening ; a hub comprising a central frame , an upper surface portion and a plurality of combining blocks , the central frame having a central hole , the upper surface portion being formed at an end of the central frame, the combining blocks being formed on the upper surface portion and being inserted between the fixing units; characterised by an elastic unit integrally formed, and disposed on the fixing units or beneath the upper surface portion; and a combining unit fixing the fixing units, the upper surface portion and the elastic unit with each other.
A compound of structural Formula (I): or a salt thereof, wherein: R 1 is selected from and ; n is selected from 1 and 2, inclusive; R 2 is a 5- to 10-membered heteroaryl, and is optionally substituted with one or more R 5 groups; R 3 is methyl; R 4a is selected from H, alkyl, and C 3-7 cycloalkyl; R 4b is selected from C(O)R 6 , C(O)OR 6 , and C(O)NR 7 R 8 ; each R 5 is independently selected from amino, fluoro, chloro, cyano, C 1-3 alkyl, C 1-3 aminoalkyl, C 1-3 haloalkyl, C 1-3 alkoxy, C 1-3 hydroxyalkyl, C 1-3 haloalkoxy, C 3-7 cycloalkyl, and 5- to 10-membered heterocycloalkyl; each R 6 , R 7 , and R 8 is independently selected from H, C 1-3 alkyl, C 3-7 cycloalkyl, C 1-3 hydroxyalkyl, (C 1-3 alkoxy)C 1-3 alkyl, (C 3-7 cycloalkyl)C 1-3 alkyl, and 5- to 10-membered heterocycloalkyl and is optionally substituted with one or more R 9 ; R 7 and R 8 , together with the nitrogen to which they are both attached, optionally form a 5- to 10-membered heterocycloalkyl ring containing one or two heteroatoms; each R 6 , R 7 , or R 8 can form a ring with R 4 ; each R 9 is independently selected from halo, hydroxy, C 1-3 alkyl, C 1-3 haloalkyl, C 3-7 cycloalkyl, 5- to 10-membered heterocycloalkyl, and C 1-3 alkoxy; and each R 10 is independently selected from H, C 1-3 alkyl, C 1-3 alkoxy, C 1-3 haloalkyl, C 3-7 cycloalkyl, and 5- to 10-membered heterocycloalkyl. R 1 is selected from and ; n is selected from 1 and 2, inclusive; R 2 is a 5- to 10-membered heteroaryl, and is optionally substituted with one or more R 5 groups; R 3 is methyl; R 4a is selected from H, alkyl, and C 3-7 cycloalkyl; R 4b is selected from C(O)R 6 , C(O)OR 6 , and C(O)NR 7 R 8 ; each R 5 is independently selected from amino, fluoro, chloro, cyano, C 1-3 alkyl, C 1-3 aminoalkyl, C 1-3 haloalkyl, C 1-3 alkoxy, C 1-3 hydroxyalkyl, C 1-3 haloalkoxy, C 3-7 cycloalkyl, and 5- to 10-membered heterocycloalkyl; each R 6 , R 7 , and R 8 is independently selected from H, C 1-3 alkyl, C 3-7 cycloalkyl, C 1-3 hydroxyalkyl, (C 1-3 alkoxy)C 1-3 alkyl, (C 3-7 cycloalkyl)C 1-3 alkyl, and 5- to 10-membered heterocycloalkyl and is optionally substituted with one or more R 9 ; R 7 and R 8 , together with the nitrogen to which they are both attached, optionally form a 5- to 10-membered heterocycloalkyl ring containing one or two heteroatoms; each R 6 , R 7 , or R 8 can form a ring with R 4 ; each R 9 is independently selected from halo, hydroxy, C 1-3 alkyl, C 1-3 haloalkyl, C 3-7 cycloalkyl, 5- to 10-membered heterocycloalkyl, and C 1-3 alkoxy; and each R 10 is independently selected from H, C 1-3 alkyl, C 1-3 alkoxy, C 1-3 haloalkyl, C 3-7 cycloalkyl, and 5- to 10-membered heterocycloalkyl.
An acetabular cup prosthesis comprising: a cup having an inner cup surface and an outer cup surface , said inner cup surface meeting said outer cup surface at a rim of said cup prosthesis , wherein said inner cup surface , said outer cup surface or both said inner cup surface and said outer cup surface comprises a lip-member engagement formation located proximal to said rim , said lip-member engagement formation extending around at least a portion of the circumference of the cup prosthesis ; and a lip member comprising a cup-surface engagement formation configured to cooperate with the lip-member engagement formation of the inner cup surface or the outer cup surface ; characterised in that the lip member , once in position, is arranged to sit on and partially overlie the rim of the cup prosthesis to increase the height of the cup prosthesis , a free-end of the lip member extending upwardly and inwardly to form an artificial labrum. a cup having an inner cup surface and an outer cup surface , said inner cup surface meeting said outer cup surface at a rim of said cup prosthesis , wherein said inner cup surface , said outer cup surface or both said inner cup surface and said outer cup surface comprises a lip-member engagement formation located proximal to said rim , said lip-member engagement formation extending around at least a portion of the circumference of the cup prosthesis ; and a lip member comprising a cup-surface engagement formation configured to cooperate with the lip-member engagement formation of the inner cup surface or the outer cup surface ; characterised in that the lip member , once in position, is arranged to sit on and partially overlie the rim of the cup prosthesis to increase the height of the cup prosthesis , a free-end of the lip member extending upwardly and inwardly to form an artificial labrum.
A method of generating a strand specific cDNA molecule from an RNA molecule in an RNA sample, the method comprising: (a) isolating the RNA sample from a biological sample, and optionally fragmenting the isolated RNA; (b) generating an RNA-complementary DNA (cDNA) duplex comprising the RNA molecule and a first cDNA strand by reverse transcription; (c) annealing a partially double stranded oligonucleotide 5' adapter to the 3' end of the first cDNA strand of the RNA-cDNA duplex, wherein the 5' adapter comprises: (i) a first strand capturing oligonucleotide comprising at least 20 deoxyribonucleotides and a 3' overhang comprising about 6-12 consecutive random deoxyribonucleotides that anneal to the 3' end of the first cDNA strand, optionally wherein the 3' overhang comprises about 8-12 consecutive deoxyribonucleotides that are 100% complementary to the first cDNA strand; and (ii) a second strand blocking oligonucleotide comprising at least 20 deoxyribonucleotides complementary to at least a portion of the first strand capturing oligonucleotide; and (d) generating the strand specific cDNA molecule by extending the first strand capturing oligonucleotide of the 5' adapter using a DNA polymerase or a fragment thereof to generate a second cDNA strand complementary to the first cDNA strand. (a) isolating the RNA sample from a biological sample, and optionally fragmenting the isolated RNA; (b) generating an RNA-complementary DNA (cDNA) duplex comprising the RNA molecule and a first cDNA strand by reverse transcription; (c) annealing a partially double stranded oligonucleotide 5' adapter to the 3' end of the first cDNA strand of the RNA-cDNA duplex, wherein the 5' adapter comprises: (i) a first strand capturing oligonucleotide comprising at least 20 deoxyribonucleotides and a 3' overhang comprising about 6-12 consecutive random deoxyribonucleotides that anneal to the 3' end of the first cDNA strand, optionally wherein the 3' overhang comprises about 8-12 consecutive deoxyribonucleotides that are 100% complementary to the first cDNA strand; and (ii) a second strand blocking oligonucleotide comprising at least 20 deoxyribonucleotides complementary to at least a portion of the first strand capturing oligonucleotide; and (i) a first strand capturing oligonucleotide comprising at least 20 deoxyribonucleotides and a 3' overhang comprising about 6-12 consecutive random deoxyribonucleotides that anneal to the 3' end of the first cDNA strand, optionally wherein the 3' overhang comprises about 8-12 consecutive deoxyribonucleotides that are 100% complementary to the first cDNA strand; and (ii) a second strand blocking oligonucleotide comprising at least 20 deoxyribonucleotides complementary to at least a portion of the first strand capturing oligonucleotide; and (d) generating the strand specific cDNA molecule by extending the first strand capturing oligonucleotide of the 5' adapter using a DNA polymerase or a fragment thereof to generate a second cDNA strand complementary to the first cDNA strand.
A method for making capsules or tablets containing Serenoa Repens oil in effective and stable association with Tadalafil, for the treatment and prevention of benign prostatic hypertrophy, characterized in that it involves the adsorption of the Serenoa oil onto a solid excipient consisting of granular mesoporous silica according to a specific operating procedure which allows the preparation of a solid pharmaceutical form - tablets or opercolated capsules- in which two active and pharmacologically tested ingredients, naturally occurring in a different physical state, such as Serenoa oil and Taladafil, are coupled.
Method for welding by means of a non-consumable electrode , in particular a tungsten electrode, a welding current (I) alternating in polarity at a welding frequency (f s ) being impressed by a current source between the electrode and a workpiece in order to form an arc , and after a polarity change, the welding voltage (U) and the welding current (I) between the electrode and the workpiece being measured and the voltage (U) being compared with a preset voltage threshold value (U s+ , U s- ) and the welding current (I) being compared with a preset current threshold value (I s+ , I s- ), and the polarity being changed back to the polarity before the polarity change if the voltage (U) is above the voltage threshold value (U s+ , U s- ) and the welding current (I) is below the current threshold value (I s+ , I s- ), characterised in that , after a preset duration (Δt) after the polarity change, the welding voltage (U) and the welding current (I) are compared with the voltage threshold value (U s+ , U s- ) and the current threshold value (I s+ , I s- ), and in addition the power (P) in the arc is determined, and the polarity is then changed back to the polarity before the polarity change if the welding voltage (U) is greater than the voltage threshold value (U s+ , U s- ) and/or the welding current (I) is less than the current threshold value (I s+ , I s- ), and/or the determined power (P) is less than a preset power threshold value (P s ).